Literature DB >> 32356366

Effects of extracellular vesicles released by peritoneal B-1 cells on experimental Leishmania (Leishmania) amazonensis infection.

Maytê Dos Santos Toledo1, André Cronemberger-Andrade2, Fernanda Marins Costa Barbosa1, Natasha Ferraz de Campos Reis1, Talita Vieira Dupin1, Rodrigo Pedro Soares3, Ana Claudia Torrecilhas1,2, Patricia Xander1.   

Abstract

B-1 cells are a B-lymphocyte subtype whose roles in immunity are not completely defined. These cells can produce cytokines (mainly IL-10) and natural and specific antibodies. Currently, extracellular vesicles (EVs) released by immune cells have emerged as new important entities in cell-cell communication. Immune cells release EVs that can activate and/or modulate other immune cells. Here, we characterized the EVs released by peritoneal B-1 cells infected or not with Leishmania (Leishmania) amazonensis. This Leishmania species causes cutaneous leishmaniasis and can infect macrophages and B-1 cells. Our results showed that peritoneal B-1 cells spontaneously release EVs, but the parasite stimulated an increase in EVs production by peritoneal B-1 cells. The treatment of BALB/c and C57BL/6 bone marrow-derived macrophages (BMDM) with EVs from infected peritoneal B-1 cells led to differential expression of iNOS, IL-6, IL-10, and TNF-α. Additionally, BALB/c mice previous treated with EVs released by peritoneal B-1 cells showed a significant lower lesion size and parasite burden. Thus, this study demonstrated that peritoneal B-1 cells could release EVs that can alter the functions of macrophages in vitro and in vivo these EVs altered the course of L. amazonensis infection. These findings represent the first evidence that EVs from peritoneal B-1 cells can act as a new mechanism of cellular communication between macrophages and B-1 cells, contributing to immunity against experimental leishmaniasis. ©2020 Society for Leukocyte Biology.

Entities:  

Keywords:  B-1 cells; Leishmania (L.) amazonensis; extracellular vesicles; macrophages

Mesh:

Substances:

Year:  2020        PMID: 32356366     DOI: 10.1002/JLB.3MA0220-464RR

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  5 in total

1.  Protein methyltransferase 7 deficiency in Leishmania major increases neutrophil associated pathology in murine model.

Authors:  Juliana Alcoforado Diniz; Mariana M Chaves; Slavica Vaselek; Rubens D Miserani Magalhães; Rafael Ricci-Azevedo; Renan V H de Carvalho; Lucas B Lorenzon; Tiago R Ferreira; Dario Zamboni; Pegine B Walrad; Petr Volf; David L Sacks; Angela K Cruz
Journal:  PLoS Negl Trop Dis       Date:  2021-03-02

Review 2.  Extracellular Vesicles in Trypanosomatids: Host Cell Communication.

Authors:  Ana Claudia Torrecilhas; Rodrigo Pedro Soares; Sergio Schenkman; Christopher Fernández-Prada; Martin Olivier
Journal:  Front Cell Infect Microbiol       Date:  2020-12-14       Impact factor: 5.293

3.  Long-Term In Vitro Passaging Had a Negligible Effect on Extracellular Vesicles Released by Leishmania amazonensis and Induced Protective Immune Response in BALB/c Mice.

Authors:  Talita Vieira Dupin; Natasha Ferraz de Campos Reis; Elizabeth Cristina Perez; Rodrigo Pedro Soares; Ana Claudia Torrecilhas; Patricia Xander
Journal:  J Immunol Res       Date:  2021-12-24       Impact factor: 4.818

4.  Leishmania amazonensis Promastigotes or Extracellular Vesicles Modulate B-1 Cell Activation and Differentiation.

Authors:  Natasha Ferraz de Campos Reis; Talita Vieira Dupin; Carolina Rizzaro Costa; Maytê Dos Santos Toledo; Vivian Cristina de Oliveira; Ana Flavia Popi; Ana Claudia Torrecilhas; Patricia Xander
Journal:  Front Cell Infect Microbiol       Date:  2020-10-30       Impact factor: 5.293

5.  Immunomodulatory Properties of Leishmania Extracellular Vesicles During Host-Parasite Interaction: Differential Activation of TLRs and NF-κB Translocation by Dermotropic and Viscerotropic Species.

Authors:  Paula Monalisa Nogueira; Armando de Menezes-Neto; Valéria M Borges; Albert Descoteaux; Ana Claudia Torrecilhas; Patrícia Xander; Or-Yam Revach; Neta Regev-Rudzki; Rodrigo Pedro Soares
Journal:  Front Cell Infect Microbiol       Date:  2020-07-29       Impact factor: 5.293

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.